Description
EXARIO 625-LB is a combination antibiotic and probiotic formulation designed to provide comprehensive treatment for bacterial infections while promoting gut health. It contains Amoxicillin (500mg), a broad-spectrum antibiotic, Clavulanic Acid (125mg), a beta-lactamase inhibitor, and Lactic Acid Bacillus (60 Million Spores), a beneficial probiotic.
Amoxicillin (500mg): Amoxicillin is a penicillin-type antibiotic that works by inhibiting the synthesis of bacterial cell walls, leading to the death of the bacteria. It is effective against a wide variety of bacterial infections, including respiratory, urinary, skin, and gastrointestinal infections.
Clavulanic Acid (125mg): Clavulanic acid is a beta-lactamase inhibitor that helps protect Amoxicillin from being inactivated by beta-lactamase enzymes produced by resistant bacteria. This enhances the effectiveness of Amoxicillin, allowing it to treat infections caused by bacteria that would otherwise be resistant to the antibiotic.
Lactic Acid Bacillus (60 Million Spores): Lactic Acid Bacillus is a probiotic strain that helps restore the balance of beneficial bacteria in the gut. Antibiotic use can often disrupt this balance, leading to gastrointestinal issues such as diarrhea. The addition of Lactic Acid Bacillus helps protect and restore gut flora, reducing the risk of antibiotic-associated diarrhea and improving digestive health.
EXARIO 625-LB is especially useful for treating infections such as sinusitis, bronchitis, pneumonia, urinary tract infections, and skin infections. The inclusion of Lactic Acid Bacillus helps mitigate the gastrointestinal side effects typically associated with antibiotics, ensuring a more comfortable treatment experience.
